EBIT (Annual)

EBIT: Income before interest and taxes.

bioAffinity Technologies, Inc. (BIAF) had EBIT of $-10.57M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$6.16M
Net Income	$-14.91M
Cost of Goods Sold	$4.23M
Gross Profit	$1.94M
Operating Expenses	$16.73M
Operating Income	$-10.57M
Non-Operating Income/Expense	$-4.29M
Pre-Tax Income	$-14.87M
Normalized Pre-Tax Income	$-14.87M
Income after Taxes	$-14.91M
Income from Continuous Operations	$-14.91M
Consolidated Net Income/Loss	$-14.91M
Normalized Income after Taxes	$-14.91M
EBIT	$-10.57M
EBITDA	$-10.07M
Weighted-Average Shares Outstanding (Basic)	1.72M
Weighted-Average Shares Outstanding (Diluted)	1.72M
Earnings per Share (EPS) (Basic)	$-8.66
Earnings per Share (EPS) (Diluted)	$-8.66
Balance Sheet Financials
Current Assets	$7.57M
Property, Plant, and Equipment	$0.27M
Long-Term Assets	$3.40M
Total Assets	$10.96M
Current Liabilities	$2.91M
Long-Term Debt	$0.57M
Long-Term Liabilities	$0.78M
Total Liabilities	$3.68M
Common Equity	$7.28M
Tangible Shareholders Equity	$5.16M
Shareholders Equity	$7.28M
Common Shares Outstanding	4.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.33M
Cash Flow from Investing Activities	$-0.06M
Cash Flow from Financial Activities	$14.73M
Beginning Cash	$1.11M
End Cash	$6.45M
Increase/Decrease in Cash	$5.34M
Stock-Based Compensation	$0.67M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.60
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.11
Gross Margin	31.41%
Operating Margin	-171.58%
EBIT Margin	-171.58%
EBITDA Margin	-163.38%
Pre-Tax Profit Margin	-241.25%
Profit Margin	-241.96%
Free Cash Flow	$-9.39M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.56
Inventory Turnover	78.93
Receiveable Turnover	11.37
Days Sales in Receivables	32.10
Return on Equity	-204.87%
Return on Tangible Equity	-289.15%
Return on Assets	-136.03%
Return on Investments	-189.89%
Book Value Per Share	$1.62
Free Cash Flow per Share	$-5.46
Operating Cash Flow per Share	$-5.42

Data from Zacks Investment Research, Inc.